COSM News and Press, Cosmos Holdings Inc. From 02/01/23

CHICAGO, IL / ACCESSWIRE / February 1, 2023 / Cosmos Health Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, is pleased to announce the app...

Cosmos Health ( NASDAQ: COSM ) has announced a share repurchase program to purchase up to $3M of its common stock. The program, which expires on January 23, 2024, will be funded using the company's working capital. As of December 31, 2022, Cosmos ( COSM ) had cash, cash equiva...

CHICAGO, IL / ACCESSWIRE / January 24, 2023 / Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that its Boar...

Cosmos Health ( NASDAQ: COSM ) said on Friday that it extended and updated its agreement to acquire ZipDoctor from American International Holdings ( OTCQB:AMIH ). Cosmos noted that it successfully renegotiated the acquisition price of ZipDoctor to achieve improved payment terms. ...

Tapping Into the Fast Growing Multi Billion Dollar U.S. Telehealth Market CHICAGO, IL / ACCESSWIRE / January 20, 2023 / Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, brande...

Reduced its debt by 78% from $21.2M in 2021 to $4.6M in 2022 and expects interest expense in 2023 to be $0.6M versus $2.2M in 2022. CHICAGO, IL / ACCESSWIRE / January 17, 2023 / Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of...

Summary In 2022, Cosmos' share price plummeted more than 90% as it was caught in the midst of market turmoil. The completion of a reverse stock split and official compliance with Nasdaq listing requirements have improved investor perception. The CEO's ongoing personal investments an...

Healthcare distributor Cosmos Health ( NASDAQ: COSM ) announced Tuesday that the company extended and updated its previously disclosed agreement to acquire the Greek pharmaceutical company CANA Laboratories. “Cosmos Health has successfully renegotiated the acquisition price of ...

Vertically Integrating its Manufacturing and R&D Capabilities and Expanding its Product Pipeline with New Brands CHICAGO, IL / ACCESSWIRE / January 10, 2023 / Cosmos Health, Inc. ("the Company") (Nasdaq:COSM) , a global healthcare group with proprietary lines of nutraceuticals...

Cosmos Health ( NASDAQ: COSM ) has successfully cured the Nasdaq minimum bid price deficiency. The Company achieved this by effecting a 1 for 25 reverse stock split on its common stock on December 16, 2022. COSM has regained Nasdaq compliance as it has had a closing bid price ...